Crispr Therapeutics Ag (CRSP)

EV/EBITDA

-11.71×

TTM · Retrieved:

CRSP logo

CRSP EV/EBITDA

Current (TTM)-11.71×
CRSP Quarterly EV/EBITDA (0.00× → -52.09×)
High-resolution chart · PNG

CRSP ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag EV/EBITDA — Quarterly
Period endingEV/EBITDA
-52.0856×
-41.8898×
-38.2457×
-59.4865×
-20.9932×
-22.3484×
-103.5383×
-49.8738×
-35.9865×
-45.9702×
51.2028×
-31.067×
-59.0146×
-73.98×
-28.1644×
-28.4547×
-25.8109×
-25.9158×
-38.5019×
-63.0279×
14.1067×
-72.1389×
-91.5678×
-54.0179×
-45.9657×
-24.2429×
209.7835×
11.8149×
-40.0074×
-30.3666×
-19.8865×
-31.2938×
-66.7944×
-67.07×
471.0034×
-20.3208×
-17.8092×
-28.7636×
-21.3641×
-22.9385×
-18.4312×
-18.1497×
-24.4801×
0×
0×
0×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.